Want to join the conversation?
$MON 3Q15 Call –Pierre, CFO: YTD, out total operating expense were flat with prior year, effectively absorbing more than $100MM of inflationary increases & ramping spend on our new climate & biological platforms. We’ve successfully completed our $6Bil accelerated share buyback program & now our share count now stands at 469MM shares outstanding.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.